ClavystBio

CEO and founding member of ClavystBio with over 20 years of experience investing in private and public life sciences and healthcare companies globally, previously leading life sciences investments at Temasek and venture investments in China and USA at UOB Venture Management.

CFO with over 20 years of finance and investment experience across Singapore, Hong Kong, China, and Australia; previously served as Group CFO of Luye Medical Group and CFO of Docquity.

Finance director with over 20 years of finance management experience; previously held roles at Temasek International overseeing corporate accounting, international office finance, and global financial transformation.

Oversees digital health and medtech ventures with extensive experience across private and corporate venture capital, previously Managing Director at Heritas Capital and Partner at Philips Ventures.

Investment and venture-building leader focused on healthcare companies from Singapore with prior experience heading Singapore investments at Lightstone Ventures and expertise in biopharmaceutical and medical device sectors.

Investment and venture-building professional with experience spanning R&D, ventures, and operations in life sciences, agrifood, and semiconductors; previously held roles at A*STAR and Applied Materials.

Director combining commercial and public sector experience in venture capital investing, business strategy, and innovation policy across biotech and medtech; previously at Lightstone Ventures and National Research Foundation.

Leads the fund's communications strategy. Previously senior media relations manager and science writer at Harvard T.H. Chan School of Public Health, and worked for Partners In Health.

Portfolio Manager for InnoVenture Iowa's public co-investment fund, working with portfolio-company boards and founders on follow-on strategy. She has over 20 years of operations and business development experience, including time with BioConnect Iowa.

Co-founder of Highlander Health and healthcare innovation leader; previously principal deputy commissioner of the U.S. Food and Drug Administration and held roles at Flatiron Health and Duke University.

Pharmaceutical and biotech industry veteran with over 25 years of experience including 12 years in executive leadership at Roche and board positions at biotech companies; previously partner at venture capital firms.

CEO of Fogarty Innovation with over 30 years of medical device industry leadership; previously led businesses at Medtronic following acquisitions and held CEO roles at multiple medtech companies.

Executive assistant and office manager with over a decade of high-level administrative experience at executive search and consultancy firms in Asia.

Medical professional bringing clinical expertise to healthcare investing with over a decade in the medical industry; previously part of Temasek Life Sciences team and practiced medicine in Australia.

Managing Director at Temasek leading Asia Pacific and healthcare investments; previously managed healthcare and life sciences investment activities across multiple global regions.

HR professional managing operations, talent management, and recruitment with prior experience as HR Business Partner at early-stage biotech firms in Singapore.

Infrastructure manager overseeing operations of collaboration space with over a decade of diagnostic laboratory operations experience.

Community engagement and events manager focused on facilitating thought leadership discussions in the life sciences ecosystem; previously worked as Assistant Manager at Singapore's National Environment Agency.

Legal expert overseeing venture building efforts with nearly 20 years of progressive legal experience spanning public, private, and social sectors; previously served as General Counsel at biotech and deep tech startups.

Healthcare industry executive and entrepreneur with three decades of leadership experience; founded and exited multiple healthcare companies and previously served as Chief Scientific Officer at UnitedHealth Group.

Venture creation and investment professional with over a decade of experience across venture capital, biotech, and translational research; previously held roles at Danaher, Heritas Capital, and A*STAR.

Founding team member driving business development and operations focused on improving connectivity within the life sciences ecosystem; previously Vice President at Temasek.

Executive assistant with over 15 years of experience supporting executive teams; previously held talent and administrative roles at executive search firms and property company.

Physician and healthcare leader serving as Senior Advisor to Rush University System for Health; previously Dean of Rush Medical College and Duke-NUS Graduate Medical School.

Infrastructure leader overseeing development of ClavystBio's lab facility at Science Park; previously held technical and quality control roles in pharma and biotech sectors.

Finance and compliance professional supporting ClavystBio's financial and regulatory matters; previously worked at KPMG and Lightstone Ventures.

Healthcare executive with 12 years on BioNTech's management board where he led fundraising and commercialization generating over $22 billion in cash; held commercial roles at major pharma companies.

Professional board member in biotech and life sciences with extensive M&A and corporate finance expertise; previously CFO of Denali Therapeutics and Genentech, and global M&A head at Roche.

Venture Partner at ARCH Venture Partners and board chair of biotech companies; previously Professor at Harvard Business School and Harvard Faculty of Arts and Sciences, and President of Vertex Pharmaceuticals.

IT and cybersecurity leader with over 15 years of experience designing and implementing secure IT frameworks; brings expertise in governance, compliance, and data privacy across e-commerce and logistics sectors.

Investment professional combining expertise in biomedical research, intellectual property, and venture investment to support scientists and startups; previously worked as researcher at A*STAR and patent attorney.

Investment professional passionate about translating and commercializing life science research with experience at Xora Innovation and Experimental Drug Development Centre.

Investment and venture creation professional focused on translating scientific research into companies; previously worked at a venture firm focusing on early-stage biotech and as a consultant in the life sciences industry.

Ed has founded and exited two media and technology businesses and is an active angel investor in the green and technology sectors.

Kieran O'Neill is a Principal at Tidal Ventures, where he invests in early-stage B2B and Vertical AI software, with an interest in regulated and asset-intensive sectors. Before venture capital, he worked in finance at KPMG, Goldman Sachs, Lloyds Bank, and Macquarie Bank, and later at managed services provider VMTech, and holds a Commerce degree in Finance and Accounting from the University of Queensland along with a Chartered Accountant qualification. He co-founded the proptech startup Hometime, where he led functions including go-to-market, finance, strategy, acquisitions, and team building.

Sonja has 26 years of experience across financial institutions in Switzerland, New York and Hong Kong, spanning corporate banking, wealth management and leadership. She holds a Bachelor's in Controlling from HWZ Zurich and is a CFA and CAIA charterholder.